Reta~trutide
Reta~trutide
Other recommendations
Cantidad
El pedido mínimo es: 2 boxsEnvío
El proveedor enviará en 3–10 días a partir del pago confirmado.
Los productos se despacharán desde United Kingdom, China el puerto.
El envío se ofrece bajo términos FOB — el proveedor cubre los costos hasta el puerto de embarque designado.
Pago: Western Union
Muestra disponible · $300.00/muestra
Euromart Suppliers protección de pedido
Cada pago que realizas está protegido con estricto cifrado SSL y protocolos de protección de datos PCI DSS
Realiza devoluciones locales gratuitas por defectos en compras elegibles
Solicita un reembolso si tu pedido no se envía, falta o llega con problemas
Meet your supplier
Distributor / Wholesaler • 3 yr • 
UNITED KINGDOM
56%
On-time delivery rate
≤24h
Response Time
75
Employee Size
$500K
Annual Revenue
588
Products Sold
Location
Belfast, United Kingdom
Other recommendations
KEY FEATURES
Therapeutic Class: Investigational peptide therapy
Mechanism of Action: Triple receptor agonist (GIP, GLP‑1, glucagon)
Primary Uses (Investigational): Obesity management, metabolic regulation, type 2 diabetes (under study)
Clinical Benefits (Trial Data):
Up to 24–25% body weight reduction in <1 year
Improved glucose metabolism and insulin sensitivity
Appetite suppression and increased energy expenditure
Status: Not FDA‑approved; currently in Phase II/III clinical trials
TECHNICAL SPECIFICATIONS
Molecular Type: Synthetic peptide (LY‑3437943)
Administration Route: Subcutaneous injection (once weekly)
Formulation: Prefilled injection pens (trial use)
Stability & Storage: Refrigerated until use; stability data under investigation
Safety Profile (Investigational):
GI side effects (nausea, diarrhea)
Risks under study: bone health, kidney complications, rapid weight loss
Regulatory Identifiers: Not yet assigned ATC code or HS classification (pending approval)
AVAILABLE CONFIGURATIONS
Format & Delivery:
Prefilled injection pens (trial formulations)
Bulk API (research supply only)
Concentration & Dosing:
Investigational fixed strengths (dose escalation in trials)
No commercial dosing yet established
Packaging & Labeling:
Clinical trial packaging only
Future potential: finished product packaging, private labeling (post‑approval)
Ratings & Reviews
From Other Suppliers
Ozempic 2 Pens 0.25mg + 0.5mg Wholesale & Retail in Europe, UK, USA, Asia
MOQ: 8 pieces71 sold
USOzempic Injection – Semaglutide Injection 025mg 0.5mg 1mg, 1 Pen
MOQ: 10 pieces31 sold
USOzempic Pens 0.25mg Wholesale & Retail in Europe, UK, USA, Asia
MOQ: 6 pieces39 sold
US
GB
